Y Mao, L Zhu, Z Huang, C Luo, T Zhou… - Endocrine-Related …, 2020 - erc.bioscientifica.com
Sorafenib, a small-molecule tyrosine kinase inhibitor with antiangiogenic activity, has been
used in liver cancer and kidney cancer treatments. However, clinical trials with sorafenib for …